EMPLOYMENT AGREEMENTEmployment Agreement • March 9th, 2015 • Sucampo Pharmaceuticals, Inc. • Pharmaceutical preparations
THIS EMPLOYMENT AGREEMENT (the "Agreement"), dated as of October 21, 2014, is hereby entered into in the State of Maryland by and between SUCAMPO PHARMA AMERICAS, LLC., a Delaware limited liability company (the "Company"), and Peter Kiener ("Executive").
MANUFACTURING AND SUPPLY AGREEMENT BY AND BETWEEN SUCAMPO AG AND PAR PHARMACEUTICAL, INC. DATED AS OF FEBRUARY 5, 2015Manufacturing and Supply Agreement • March 9th, 2015 • Sucampo Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Manufacturing and Supply Agreement (this “Agreement”) is hereby entered into and effective as of February 5, 2015 (the “Effective Date”) by and between Sucampo AG (“Sucampo”) and Par Pharmaceutical, Inc. (“Par”). Each of Sucampo and Par are referred hereto as the “Parties” or, individually, as a “Party”).
STIPULATION AND LICENSE AGREEMENTLicense Agreement • March 9th, 2015 • Sucampo Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
THIS STIPULATION AND LICENSE AGREEMENT (this “Agreement”) is made and entered into as of February 5, 2015 (the “Effective Date”) by and between, on the one hand, Sucampo AG and Sucampo Pharmaceuticals, Inc. (collectively, “Sucampo”) and R-Tech Ueno, Ltd. (“RTU”), and on the other hand, Par Pharmaceutical, Inc. (“Par”). Each of Sucampo, RTU, and Par is a “Party” and, together, are the “Parties” with respect to the following:
EMPLOYMENT AGREEMENTEmployment Agreement • March 9th, 2015 • Sucampo Pharmaceuticals, Inc. • Pharmaceutical preparations
LICENSE, DEVELOPMENT, COMMERCIALIZATION AND SUPPLY AGREEMENT FOR LUBIPROSTONE by and between Takeda Pharmaceuticals International GmbH and SUCAMPO AG Dated as of October 17, 2014License, Development, Commercialization and Supply Agreement • March 9th, 2015 • Sucampo Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
